Postpartum Intervention for Mothers With Opioid Use Disorders
This study is looking at an intervention called "Mom Power" for mothers with opioid use disorder (OUD) who have a child aged 5 or less. Mom Power is a program designed to help mothers with their mood and parenting skills. Researchers want to see if this program, delivered virtually (online or by phone), can help reduce drug use and improve mood in mothers with OUD. You may be able to join if you are a mother between 18 and 50 years old, have an OUD diagnosis or are receiving medication-assisted treatment (like buprenorphine or methadone), and can understand English. The study aims to enroll 50 participants, but its current status is unclear.
- Study design
- This is an interventional study, meaning participants will receive a specific intervention. It plans to enroll 50 participants.
- What's involved
- Experimental participants will receive virtual Mom Power via phone/internet connection. Control participants will receive mail information and confirmation phone calls.
- Compensation
- Not stated in the trial record.
- Follow-up
- The primary endpoints are measured at less than 2 years.
AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.
Postpartum Intervention for Mothers With Opioid Use Disorders
At a glance
Conditions
Where it's being run
2 sites across 2 statesStudy leadership
- James E Swain, MD, PhD · PRINCIPAL_INVESTIGATOR · Stony Brook University
Who to contact
Opens a ready-to-send draft in your own email app — review before sending.
Do you actually qualify for this trial?
Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.
Inclusion
What this trial measures
- R61 Milestone 1<2 years
To recruit at least N = 50 participants in 11.25 months for the expanded number in the R33
- R61 Milestone 2<2 years
To end with 80% of mothers in the MP condition attending \>=80% of sessions
- R61 Milestone 3<2 years
To end with \>=70% yielding satisfactory pre- and post-intervention ERP and fMRI data
- R61 Milestone 4<2 years
To show that vMP for OUD significantly affects ERP (LPP and N170) and drug craving, mood, and parenting stress (P\<0.05)